Retatrutide is an advanced weight loss peptide that works by activating three different hormone receptors: GLP-1, GIP, and glucagon
These GLP-1 agonists can be a two-in-one solution for diabetes and weight loss, Robert Fontana, MD, a Michigan Medicine hepatologist said in an online interview, maybe a three-in-one solution if they prove to be safe and effective for metabolic associated steatohepatitis as well. When asked about the benefits observed in patients using GLP-1RA medications for conditions other than diabetes, the top five areas of improvement that physicians reported included weight loss (92 percent), positive effects on lipid profiles (57 percent), reduced cravings or dependency behaviors (56 percent), reduced blood pressure (48 percent), and reduced inflammation (46 percent)
This shift in understanding may have as much impact as any drug
Approximately 90% of the drug is rapidly inactivated by plasma pseudocholinesterase , while only about 10% reaches the neuromuscular junction (NMJ)
Nanocarrier formulations Nanoparticles, liposomes, and nanoemulsions can encapsulate retatrutide and protect it from enzymatic degradation while facilitating epithelial transport